Terveystalo Oy Class A · OMXHEX:TTALO
Terveystalo Oy Class A — Q1 2025 Earnings Presentation
16 slides from Terveystalo Oy Class A's earnings presentation, 2025
Slide 1: Terveystalo Group Q1 2025 Results
Terveystalo Group Q1 2025 Results Ville Iho, President & CEO Juuso Pajunen, CFO
Slide 2: Agenda
Agenda Ville Iho, President & CEO Q1 2025 Financial & operational highlights Juuso Pajunen, CFO Q1 2025 Financial performance analysis Outlook & guidance Q&A 2
Slide 3: Q1 2025 highlights
Q1 2025 highlights Revenue (MEUR) EPS (EUR) 347 0.26 -0.9% y-o-y +41.4% y-o-y Adj. EBIT (MEUR) Adj. EBIT margin 47.8 13.8% +19.2% y-o-y +2.3%-p. y-o-y NPS, appointments Operating cash flow (MEUR) 88 27.3 +1.9% y-o-y -44.5% y-o-y 3
Slide 4: Each of our three business areas have a clear improvement agenda
Each of our three business areas have a clear improvement agenda Business Area Healthcare Services Portfolio Businesses Sweden LTM Revenue EUR 1,055 mill. EUR 224 mill. EUR 79 mill. LTM Adj. EBIT margin 14.4% 3.9% -3.3% Share of LTM revenue* 79% 17% 6% Turnaround and selective, Profitable growth, pr
Slide 5: Accelerating our strategic agenda: Key areas for growth
Accelerating our strategic agenda: Key areas for growth Engaged Superior value through Organic Efficiency team integrated care growth Engagement index development PEI % Group LTM adjusted EBIT development 70,8% 70,8% 4,19 4,19 70,0% 69,2% 69,8% 2,6% 1 337 68,5% 10,5% 11,1% 4,11 4,11 4,09 10,0% 4,07
Slide 6: Financial performance
Financial performance Juuso Pajunen, CFO 6
Slide 7: Q1: Solid performance at Group level
Q1: Solid performance at Group level Revenue Key figures -0,9% 1-3/2025 1-3/2024 Change, % 2024 Revenue, 12,6 -14,1 MEUR 346.9 350.2 -0.9 1,340.0 / / Adj. EBITA, 350,2 +4.7% -21.7% MEUR 53.7 47.2 13.9 171.0 -2,5 / 346,9 0,7 Adj. EBITA-% -10.8% 15.5 13.5 2.0%-p. 12.8 Adj. EBIT, MEUR 47.8 40.1 19.2 14
Slide 8: Q1: Robust results in Healthcare Services
Q1: Robust results in Healthcare Services Growth Key figures 104,7% 1-3/2025 1-3/2024 Change, % 2024 Revenue, MEUR 280.6 268.0 4.7 1,042.8 Adj. EBITA, 6,1% MEUR 50.5 43.2 16.9 162.0 100,0% Adj. EBITA-% 0,4% 18.0 % 16.1 % 1.9%-p. 15.5 % -1,6% Adj. EBIT, MEUR 47.3 39.3 20.3 143.7 Adj. EBIT-% Q1 2024 V
Slide 9: Q1: The profitability fundamentals have strengthened in the Portfolio businesses
Q1: The profitability fundamentals have strengthened in the Portfolio businesses Revenue Market update -22% 64,7 • The publicly funded market remained cautious. -10,1 • Consumer demand increased during the quarter. -4,0 50,6 0,6 -0,6 • Revenue decreased due to the planned reduction in the outsourcin
Slide 10: Q1: Difficult market conditions in Sweden, ongoing advancements in the profit improvement programme
Q1: Difficult market conditions in Sweden, ongoing advancements in the profit improvement programme Revenue Market update -11% 23,0 0,1 • The weak macroeconomic situation continued, and the -2,6 20,6 unemployment rate trended upwards. • Revenue decreased due to expired contracts and weaker demand. •
Slide 11: We invest in organic and disciplined inorganic growth
We invest in organic and disciplined inorganic growth 59 CAPEX (MEUR) • Our investment strategy prioritises organic growth and disciplined inorganic expansion. 43 30 41 40 42 • We focus on digital investments to improve user experience and productivity for healthcare 34 33 professionals. 21 4,7 25 •
Slide 12: A strong financial position supports our strategy execution
A strong financial position supports our strategy execution Strong profit growth has led to significant cash flow conversion and deleveraging Operating cash flow (LTM) 224 Net debt to EBITDA 3,5 196 202 3,4 3,3 190 3,2 174 171 3,1 152 158 2,6 143 2,3 2,2 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2018 2019 2020 202
Slide 13: Guidance for 2025
Guidance for 2025 (unchanged) Terveystalo expects its full-year 2025 revenue to grow (2024: EUR 1,340 million) and adjusted EBIT to be 10.7–11.8% of revenue (2024: 10.5%) • The estimates are based on a stable demand environment, employment levels, and typical morbidity rates. • The estimates account
Slide 14: Q&A
14 Q&A Terveystalo
Slide 15: terveystalo.com
Terveystalo MEANINGFUL MATTERS
Slide 16: The legacy outsourcing contract portfolio shrinks as old contracts expire or are terminated
The legacy outsourcing contract portfolio shrinks as old contracts expire or are terminated CO N T R AC T VA LU E , O U T S O U R C I N G CO N T R AC T S , M € ¹ 120 80 75 50 30 10 10 2022 2023 2024 2025 2026 2027 2028 16 1) ROUNDED FIGURES